New solutions for multiple myeloma patients with 14;16 and 14;20 translocations with Dr. Frank Zhan, MD, PhD and Dr. Guido Tricot, MD, PhD, University of Iowa

Personalized treatment for normal and high-risk patients using immunotherapy and transplant with Dr. Ivan Borrello, MD, PhD, Johns Hopkins

Which myeloma cells are surviving beyond chemotherapy? Newer, more sophisticated monitoring to pinpoint surviving cells in order to find better targets with Dr. Bruno Paiva, PhD, University of Navarra

Overcoming Deletion 17p Using a Specifically Targeted Therapy with Dr. Robert Orlowski, MD, PhD, MD Anderson

Remarkable approach for highly aggressive myeloma and PCL using safer allo transplant techniques in combination with immunotherapies. Dr. Guenther Koehne, MD, PhD, MSKCC

Hot immunotherapy work using CAR T cells for a common myeloma target with Dr. Craig Hofmeister, MD, OSU

The Hidden Extent of Smoldering Myeloma and a Vaccine for Smolderers with Dr. Ajay Nooka, MD

Newer approaches for relapsed/refractory myeloma patients with Dr. Ravi Vij, MD, Washington University School of Medicine

A 2015 Myeloma Therapy Preview with Dr. Robert Orlowski